Title:
癌の検出および診断のための抗体Ｉ−３８５９の使用
Document Type and Number:
Japanese Patent JP2014523920
Kind Code:
A
Abstract:
The present invention relates to the use of a novel, isolated anti-CXCR4 antibody in the diagnosis of cancer. In particular, methods for diagnosing and/or prognosing an oncogenic disorder associated with CXCR4 expression, are disclosed.
More Like This:
| WO/2020/181983 | HYPOXIA-REGULATED PROMOTER AND APPLICATION THEREOF |
| WO/2018/078066 | ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS |
| WO/2020/011968 | ANTI-CD137 ANTIBODIES |
Inventors:
Christine, the クリンゲル * Amur
Alexandra, Juan Ore
Alexandra, Juan Ore
Application Number:
JP2014522119A
Publication Date:
September 18, 2014
Filing Date:
July 30, 2012
Export Citation:
Assignee:
Pierre, Fabre, medicament
International Classes:
C07K16/28; G01N33/48; G01N33/53; G01N33/574
Domestic Patent References:
| JP2002509734A | 2002-04-02 | |||
| JP2009515148A | 2009-04-09 | |||
| JP2010505830A | 2010-02-25 | |||
| JP5800802B2 | 2015-10-28 |
Foreign References:
| WO2010125162A1 | 2010-11-04 |
Other References:
PLOS ONE, 2008, VOL. 3, ISSUE 12, E4069, JPN6016020271, ISSN: 0003327140
J. CLIN., ONCOL., 1999, VOL. 17, NO. 5, P.1474-1481, JPN6016020274, ISSN: 0003327141
J. CLIN., ONCOL., 1999, VOL. 17, NO. 5, P.1474-1481, JPN6016020274, ISSN: 0003327141
Attorney, Agent or Firm:
Katsunuma Hirohito
Yukitaka Nakamura
Nobutaka Yokota
Fujii Hiroyuki
Yukitaka Nakamura
Nobutaka Yokota
Fujii Hiroyuki